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ABSTRACT
VITAMIN D STATUS AND BONE HEALTH AMONG YOUNG ADULT WOMEN
FEBRUARY 2018
CAROLINE E. STONE, B.S., UNIVERSITY OF MASSACHUSETTS AMHERST
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Dr. Elizabeth Bertone-Johnson
Background:
Osteoporosis is estimated to affect 200 million women in the world, affecting
10% of women aged 60, 20% of women aged 70, 40% of women aged 80 and 67% of
women aged 90. Osteoporosis is characterized by low bone density and increases the risk
for fractured bones; however, it may be prevented with modifiable factors such as
supplements, diet, and physical activity. Vitamin D deficiency leads to bone mineral
density loss, as Vitamin D3 is responsible for calcium absorption into the bones. Bone
consolidation is believed to occur between 20 and 30 years old; thus, attaining peak bone
mass is critical during pre-menopause.
Methods:
The relationship between vitamin D and bone mineral density has predominately
been studied in postmenopausal populations. Therefore, we examined this association
among 18-30 year old participants (n=271) in the cross-sectional UMass Vitamin D
Status Study. The modified version of the Harvard Food Frequency Questionnaire was
used to assess the average intake of vitamin D foods and supplements. Serum 25(OH)D3
concentrations were assayed from blood samples. Bone mineral content and bone area
were measured by dual-energy X-ray absorptiometry scan. Bone mineral content (BMC),
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as measured in grams, provides a measure of bone mass. Bone area (BA), as measured in
cm2, reflects a two-dimensional area, which is characterized by the periphery of a bone
region. We used multivariable linear regression to model the relationship between bone
mineral density and bone area with sources of vitamin D after adjusting for dietary and
lifestyle factors.
Results:
In the present study, the mean and standard deviation of vitamin D is 372.7 IU
and 285.8 IU, respectively. For vitamin D from supplements, the mean is 140.9 IU with a
standard deviation of 232.3 IU. Finally, for vitamin D from food, the mean is 231.8 IU
with a standard deviation of 182.0 IU. Compared to reference values of 600 IU, these
data are below the recommended daily allowance.
We did not observe an association between total vitamin D or vitamin D from
foods sources with either BMC or BA. We also did not observe an association between
serum 25-hydroxyvitamin D levels and BMC or BA.
Conclusion:
Future studies with larger sample sizes are warranted to validate this association
among young premenopausal women.
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CHAPTER 1
INTRODUCTION
Osteoporosis is estimated to affect 200 million women in the world, affecting
10% of women aged 60, 20% of women aged 70, 40% of women aged 80 and 67% of
women aged 90.1 In 2010, there were approximately 9 million cases of osteoporosis
among American women aged 50 or older. By 2020, this figure is estimated to increase to
10.5 million cases.2 In 2005, 71% of osteoporosis-related fractures occurred among
women. Of the total costs of incident fractures, over three-quarters, or $12.8 billion, were
among women.3 Risk factors for osteoporosis are family history of osteoporosis, age, low
intake of calcium and vitamin D, physical inactivity, smoking, race, and female sex.4
Menopause leads to a decrease in estrogen, a hormone that aids in the building of new
bone.5 Thus, postmenopausal women are at an increased risk of osteoporosis.
Osteoporosis is defined as bone mineral density that is 2.5 standard deviations
below the young adult mean.6 Since bone mineral density decreases gradually with age,
having a high peak bone mass in young adulthood may prevent or delay osteoporosis
later in life. Peak bone mass is typically achieved by the age of thirty. Prior to this age,
modifiable factors such as supplements,7 diet,8 and physical activity/strength training8
may increase bone mineral density. For example, a study by Alghadir et al. assessed the
role of physical activity, calcium consumption and lifestyle factors and bone mineral
density among 350 young adult participants. This study showed that low intake of
calcium and milk, in addition to higher caffeine and carbonated beverage consumption
was negatively associated with bone mineral density status.8 Participants were classified
into groups according to their bone mineral density status. In younger subjects, more than
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72.6% had normal bone mineral density, while 22.6 and 4.8% had osteopenia and
osteoporosis, respectively. However, among women aged 25-30, participants showed
higher proportions of osteopenia (34.9%) and osteoporosis (6.9%). Compared with the
younger groups of participants, 48.2% of older men and women had normal bone mineral
density values, while 34.7% and 17.1% had osteopenia and osteoporosis, respectively.
However, among women aged 31-45, showed the highest prevalence of osteopenia
(38.5%) and osteoporosis (18.3%).8
In a study by Riggs et al, patterns of bone loss were studied among 187 normal
participants, aged 20-89 years, and in 85 participants with vertebral fractures due to
osteoporosis. Overall, the predicted mean for bone mineral density at age 90 was 47%
less than the predicted mean at age 20.9
As mentioned previously, while vitamin D is an established risk factor for
osteoporosis, it is unclear how it is associated in the attainment of peak bone mineral
density in young adults. For this reason, it is necessary to examine the modifiable factors
for peak bone density, specifically vitamin D.
Vitamin D has two forms; 1) Vitamin D2 (ergocalciferol), 2) Vitamin D3
(cholecalciferol), and several metabolites.10 Serum 25-hydroxyvitamin D concentrations
serve as a biomarker for vitamin D.11 Vitamin D3 is produced in two ways: ultraviolet B
radiation from the sun and diet. Foods such as fatty fish (3 ounces of salmon is equivalent
to 447 IU of vitamin D), milk (one cup is equivalent to 115-124 IU of vitamin D), egg
yolk (1 large egg is equivalent to 41 IU of vitamin D), and beef liver (3 ounces is equal to
42 IU of vitamin D) are sources of vitamin D3.12 It has been suggested by researchers that
approximately 5-30 minutes of sun exposure without sunscreen between 10 AM and 3
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PM at least two times a week usually leads to sufficient vitamin D synthesis.13 Vitamin
D2 is derived solely from plant sources.14 Vitamin D3 assists in bone mineralization and
activates osteoblasts and osteoclasts. Calcitrol, the hormone derived from vitamin D,
stimulates the intestines to absorb enough calcium into bone.15 Thus, a vitamin D
deficiency may lead to loss of bone mineral density.16 Only 10% to 15% of dietary
calcium and approximately 60% of phosphorus are absorbed into bones as a result of
vitamin D deficiency.16 Bone loss occurs with excessive osteoid accumulation, as well as
osteomalacia, or softening of the bones.17 Lack of sunlight exposure (i.e. through use of
sunscreen or veil) and inadequate dietary vitamin D, as well as malabsorption caused by
various gastrointestinal (GI) disorders may result in bone mineral loss.17

Physiology of the relationship between vitamin D and bone mineral density
The physiological mechanism by which vitamin D impacts bone mineral density
is stronger in premenopausal women than in postmenopausal women. This is because
peak rates of calcium accrual occur before the age of 30 years old.18 Previous studies
have shown that calcium accrual increases during puberty19 and that the highest calcium
accrual rates occur at a mean age of 12.5 and 14 years old in girls and boys,
respectively.20 After this rapid calcium accrual period, bone consolidation is believed to
occur between the ages of 20 and 30 years old,18 further indicating the need for our study.

Epidemiology of the relationship between vitamin D and bone mineral density
Only two prior studies investigated the association between vitamin D and bone
density among premenopausal women.21, 22 One case-control study21 (n=100) and one
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cross-sectional study22 (n=608) examined the association between serum 25hydroxyvitamin D and bone mineral density among 18-30 year old women. One of these
studies found that vitamin D was positively associated with bone mineral density22 while
the other resulted in a null association between vitamin D and bone mineral density.21
One of these studies adjusted for age and body mass index.22 However, neither of these
studies controlled for important confounding factors such as calcium intake and physical
activity.21, 22 Calcium and physical activity are positively associated with vitamin D and
bone mineral density; therefore, not controlling for these factors would lead to an
overestimate of the association between vitamin D and bone mineral density.31, 32
In the only cross-sectional study to assess 25-hydroxyvitamin D levels and bone
mineral density in healthy premenopausal women, Adami et al. collected serum samples
of women with regular monthly cyclic menses.22 Evaluation of bone mineral density was
performed via dual-energy X-ray absorptiometry (DXA) scan at the lumbar spine, the
femoral neck, and total hip BMD. After adjusting for age and BMI, the regression
coefficients between 25-hydroxyvitamin D concentrations and spine, femoral neck and
total hip bone mineral density were +0.084 (p=0.043), +0.013 (non-significant p-value
>0.1), and +0.021 (non-significant p-value >0.1) respectively.
In the only case-control study to assess 25-hydroxyvitamin D levels and bone
mineral density in patients with fibromyalgia syndrome, Olama et al. collected venous
blood samples.21 Bone mineral density was measured at the lumbar spine, femoral neck,
and forearm by DXA. Serum levels of 25-hydroxyvitamin D were inversely correlated
with BMD at the lumbar spine (p=0.012), however not related to bone mineral density at
the femoral neck and forearm sites.
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In summary, only two studies, to our knowledge, have examined the association
of vitamin D status and bone mineral density among premenopausal women.21, 22 These
studies found positive associations between vitamin D status and bone mineral density,
but did not control for important confounding factors such as calcium intake and physical
activity. Therefore, we propose to examine the association between dietary vitamin D
intake and serum levels of 25-hydroxyvitamin D and bone mineral density among
premenopausal participants (n=271) in the cross-sectional UMass Vitamin D Status
Study. We hypothesize that among the young women, dietary sources and supplements of
Vitamin D, and biochemical 25-hydroxyitamin D levels will be positively associated with
bone mineral content and bone area.
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CHAPTER 2
METHODS
Study population
The UMass Vitamin D Status Study recruited women aged 18-30, who live in
Amherst and the surrounding area. Women were recruited for this study between 2006
and 2011 by means of fliers posted around the University campus, by table tents near the
dining commons, and by classroom announcements.23
In a single clinic visit, the study participants completed a modified version of the
Harvard Food Frequency Questionnaire, as well as a comprehensive lifestyle and activity
questionnaire.23 The Harvard FFQ was modified from the 1986 version by the following
ways: zucchini was included in addition to eggplant, green peppers, sauerkraut, and
avocado were omitted, cole slaw and cabbage were combined into one food item, and
included beets and prunes. Body mass index (BMI) and blood pressure were directly
measured. Questions about reproductive health, premenstrual symptoms, attention deficit
hyperactivity disorder, perceived stress and medication use were collected.23 Before the
end of the study visit, questionnaires were assessed for completeness and participants
were asked to clarify any missing, unclear, or incomplete data.24 At the time of their
clinic visit, each participant provided a fasting blood sample, used to determine vitamin
D.23
Eligible women were aged 18-30 who lived in Amherst or the surrounding area.
Women were not eligible to participate in this study if they: 1) were pregnant or not
currently menstruating; 2) had a history of high blood pressure or cholesterol, kidney or
liver disease, bone disease (i.e. osteomalacia), gastrointestinal disorders, rheumatologic
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disease, multiple sclerosis, thyroid disease or hyperparathyroidism, cancer, type 1 or 2
diabetes, or polycystic ovaries; or 3) were currently taking corticosteroids, anabolic
steroids, anticonvulsants, cimetidine, or propranolol.23
We also excluded all participants who did not have complete data on bone
mineral density and vitamin D status.

Assessment of Vitamin D
Vitamin D was measured in two ways. First, a modified version of the Harvard
Food Frequency questionnaire collected the average intake of 131 foods and supplements
for the two months prior to the participant’s clinic visit.24 Vitamin D-rich foods included
in the questionnaire were fortified dairy foods, orange juice, breakfast cereals, dark meat,
and fish.23 Participants were also asked to specify the brand and the type of multivitamin
used on the food frequency questionnaire. The Harvard FFQ was analyzed at Harvard
University. Specifically, the frequency of intake of each food item was multiplied by its
vitamin D content, and then summed across all items of food. Contributions from vitamin
D supplemental sources were added to contributions from dietary vitamin D to calculate
total vitamin D intake.25 Intake of vitamin D foods and supplements from the FFQ were
examined continuously (Table 2).
The Harvard Food Frequency Questionnaire was previously validated by Willett
et al.26, 27 Four one-week dietary records and two food frequency questionnaires were
completed over one year by 173 participants. The mean correlation coefficients
comparing the dietary records and first and second food frequency questionnaires were
0.44 and 0.52, respectively. The correlation coefficients of the FFQ were high and
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reproducible indicating that a single FFQ is valid and reproducible for assessing specific
food and beverage intake.26, 27
The second technique for measuring vitamin D status was via fasting blood
samples, which were used to measure serum 25-hydroxyvitamin D3 concentrations.
Blood samples were processed and stored generally within two hours at -80 degrees
Celsius.28 Serum 25(OH)D3 concentrations were determined using DiaSorin’s
commercially available radioimmunoassay kit.28 Total serum 25-hydroxyvitaminD levels
were examined continuously (Table 2).
The radioimmunoassay available by DiaSorin used to measure serum 25hydroxyvitamin D3 concentrations has been previously validated by Hollis, as well as the
UMass Vitamin D Status Study research team.28 Both within- and between-assay
coefficient of variations were low (0.2-5.8%).28
The new recommended daily allowance is 600 IU for those aged 18-30. Thus, in
the present study, Vitamin D was also categorized into intake less than 600 IU per day
and intake greater than or equal to 600 IU per day for additional analyses (Table 7).
Vitamin D deficiency is defined as a 25-hydroxyvitamin D level less than 50 nmol/L for
those aged 18-30. In the present study, Vitamin D was also categorized into serum 25hydroxyvitamin D levels less than 50 nmol/L and levels greater than or equal to 50
nmol/L (Table 7).

Assessment of Bone mineral density
Bone mineral content (BMC) and bone area (BA) were directly measured using
what is considered the gold standard, dual-energy X-ray absorptiometry (DXA). The in

8

vivo precision of the specific DXA machine used, the GE Lunar Prodigy scanner, ranges
from 1.0-2.2% for bone mineral content.24 Bone mineral content, as measured in grams,
provides a measure of bone mass. Bone area, as measured in cm2, reflects a twodimensional area, which is characterized by the periphery of a bone region.
For the UMass Vitamin D Status study, bone mineral content and bone area was
measured during the participant’s clinic visit using DXA scan. The total body scan mode
was used on a narrow angle fan GE Lunar Prodigy Scanner (GE Lunar Corp., Madison,
WI, USA).29 Provided by the manufacturer, daily calibrations were performed using the
standard calibration phantom.24 With the exception of 31 participants, all DXA scans
were performed on the morning of the participant’s clinic visit.24 All DXA scans were
analyzed by a single examiner.24

Covariate Assessment
Information on lifestyle and demographics were collected by self-reported
questionnaire at the time of the clinic visit. Questions included smoking status and
number of cigarettes per day, and use of oral contraceptives and selective serotonin
reuptake inhibitors (Table 1).23 These variables were analyzed categorically (Table 1).
Questions regarding physical activity were based on those previously used and validated
in the Nurses Health Study II.30 Women were asked to report the time per week that they
were engaged in specific physical activities such as, walking, jogging, running,
aerobics/dancing, tennis/racket sports, swimming, yoga or Pilates, and weight training.23
Total MET-hours (i.e. Metabolic Equivalent of Task) per week was calculated for each
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specific activity.23 Physical activity in MET-hours per week was analyzed continuously
(Table 1).
Each study participant’s weight and height were directly measured and used to
calculate BMI by the following formula: weight (kg)/height (m2).23 A modified version of
the Harvard Food Frequency Questionnaire (FFQ) was used to collect data on participant
total caloric intake, as well as dietary intake of calcium. Sun exposure was determined by
self-reported time spent outdoors wearing minimal clothing, use of tanning beds, use of
sunscreen, and recent travel to sunny locations.23 The variables BMI and sun exposure
were analyzed categorically, and the variables for daily intake of calories and calcium
were analyzed continuously (Table 1).

Statistical Analysis
We present the distribution of vitamin D intake from dietary and supplement data
as well as serum 25-hydroxyvitamin D levels (Table 2) and the distribution of bone
mineral content and bone area (Table 3).
Covariate distributions were assessed against total vitamin D intake and 25(OH)D (Table
4) and against bone mineral content and bone area (Table 5). Categorical covariate
variables were assessed using t-tests or analysis of variance, as appropriate. Means,
standard deviations and p-values are reported. Continuous covariate variables were
assessed using unadjusted linear regression, modeled as the exposure/outcome as the
dependent variable and the covariate as the independent variable. Beta coefficients,
standard errors, and p-values are reported.
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Unadjusted linear regression models the association between vitamin D status and
bone mineral density. We report beta coefficients, standard errors and p-values (Table 6).
We used multivariable linear regression to examine the association between vitamin D
and bone mineral content and bone area (Table 6). Covariates were assessed for
confounding through individual inclusion into the age-adjusted model of vitamin D status
and bone mineral content and bone area. We performed the change in estimate procedure,
and covariates that resulted in a 10% change in any of the bone mineral density status
were considered confounders in the final model. Physical activity in METs, calcium
intake, BMI, total caloric intake were included in the final model due to their recognized
associations with vitamin D and bone mineral density in the current literature.31-34 The
covariates that resulted in a 10% change in either bone mineral content or bone area and
were considered confounders in the final model were age, ever smoke, and daily intakes
of calcium and protein. Thus, we retained variables age, body mass index, ever smoke,
physical activity in METs, caloric intake, calcium intake, and protein intake in our final
multivariable models. After adjustment, vitamin D measures were not associated with
bone mineral content. All analyses were performed using statistical software STATA
14.2 (StataCorp LLC).
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CHAPTER 3
RESULTS
Of the 298 participants, 290 had complete dietary vitamin D data as recorded
from the FFQ, 284 had serum 25(OH)D levels available, and 279 had complete bone
outcome data; thus, 271 were included in the present analysis as they had complete data
for our exposure and outcomes, as well as complete data recorded of our covariates. The
average age of study participants was 21.4 years old. The majority, 86% of the study
participants were white. As portrayed in Table 1, 79% of study participants were of
underweight or normal BMI, with the remaining 21% overweight, obese category I or II.
Mean vitamin D intake and bone measures in the population are presented in
tables 2 and 3. The total mean for participant self-reported vitamin D IU was 372.7
(standard deviation 285.8). Self-reported vitamin D IU for participants who took vitamin
D supplement was mean value of 140.9 (standard deviation 232.3), and for participants’
vitamin D from food was mean value of 231.8 (standard deviation of 182.0). Serum 25hydroxyvitamin D levels measured in nmol/L mean value for participants was 88.0
(standard deviation of 36.7).
Among the 271 participants, the distribution of bone mineral density status is as
follows. We observed a mean of 2547.6 g (standard deviation of 347.0 g) for bone
mineral content, and a mean of 2190.7 cm2 (standard deviation of 207.7 cm2), as
measured by dual energy X-ray absorptiometry.

Calories (kcal) (P<0.001), total fat (gm) (P=0.006), iron (mg) (P<0.001), total
calcium intake (mg) (P<0.001), protein (gm) (P<0.001), and vitamin A (IU) (P<0.001)
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measures were positively associated with total vitamin D intake (IU); however, these
were not associated with serum 25(OH)D (nmol/L). In analysis of variance, BMI (kg/m2)
was associated with both bone mineral content (g) (P<0.001) and bone area (cm2)
(P<0.001). Physical activity, in MET (hours/week) was positively associated with bone
mineral content (g) (P=0.05), but not bone area. All other covariate distributions,
presented in table 4 and 5, were not statistically significant.

Total Vitamin D intake
Vitamin D intake was not associated with BMC or BA. For example, each 100
IU/day increase in total vitamin D was associated with a 4.7 g lower BMC (P = 0.55)
Similarly, each 100 IU/day increase in total vitamin D was associated with a 0.01 cm2
lower BA (P=0.83).

Total Vitamin D from food sources
Each 100 IU/day increase in vitamin D from food sources was associated with a
17.8 g lower BMC (P = 0.23). Each 100 IU/day increase of vitamin D from foods was
associated with a 0.08 cm2 lower BA (P=0.41).

Serum 25-hydroxyvitamin D
Each 10 nmol/L increase in 25(OH)D was associated with a 5.9 g higher BMC
(P=0.25). Similarly null, each 10 nmol/L increase in 25(OH)D was associated with a
0.03 cm2 higher BA (P=0.36).
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Recommended levels of Vitamin D
The new recommended daily allowance is 600 IU for those aged 18-30. Thus, in
the present study, Vitamin D was categorized into intake less than 600 IU per day and
intake greater than or equal to 600 IU per day. The number of participants whose vitamin
D intake that was greater than or equal to the recommended allowance of 600 IU per day
was 45 (16.6%). A great majority of the study participants (n=226, 83.4%) had vitamin D
intake that was less than the recommended allowance of 600 IU/day.
In unadjusted models, the difference between those whose vitamin D intake was
less than the recommended allowance of 600 IU per day and those whose vitamin D
intake was greater than or equal to the recommended allowance of 600 IU per day is 30.3
g higher BMC (P = 0.59). The difference between those whose vitamin D intake was less
than the recommended allowance of 600 IU per day and those whose vitamin D intake
was greater than or equal to the recommended allowance of 600 IU per day is 0.14 cm2
higher BA (P = 0.68).
After adjustment, the difference between those whose vitamin D intake was less
than the recommended allowance of 600 IU per day and those whose vitamin D intake
was greater than or equal to the recommended allowance of 600 IU per day is 46.6 g
lower BMC (P = 0.41). The difference between those whose vitamin D intake were less
than the recommended allowance of 600 IU per day and those whose vitamin D intake
was greater than or equal to the recommended allowance of 600 IU per day is 0.24 cm2
lower BA (P=0.50).

Recommended levels of 25-hydroxyvitamin D
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Vitamin D deficiency is defined as a 25-hydroxyvitamin D level less than 50
nmol/L for those aged 18-30. In the present study, Vitamin D was categorized into serum
25-hydroxyvitamin D levels less than 50 nmol/L and levels greater than or equal to 50
nmol/L.
In unadjusted models, the difference between those whose 25-hydroxyvitamin D
levels less than 50 nmol/L and those whose 25-hydroxyvitamin D levels were greater
than or equal to 50 nmol/L is 110.7 g higher BMC (P = 0.095). The difference between
those whose 25-hydroxyvitamin D levels less than 50 nmol/L and those whose 25hydroxyvitamin D levels were greater than or equal to 50 nmol/L is 0.73 cm2 higher BA
(P = 0.06).
After adjustment, the difference between those whose 25-hydroxyvitamin D
levels less than 50 nmol/L and those whose 25-hydroxyvitamin D levels were greater
than or equal to 50 nmol/L is 48.3 g higher BMC (P=0.42). The difference between those
whose 25-hydroxyvitamin D levels less than 50 nmol/L and those whose 25hydroxyvitamin D levels were greater than or equal to 50 nmol/L is 0.42 cm2 higher BA
(P = 0.25).
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CHAPTER 4
DISCUSSION
Epidemiology of the relationship between vitamin D and bone mineral density
We found a null association between total vitamin D, vitamin D from foods, and
serum 25-hydroxyvitamin D and both BMC and BA. Our results are somewhat consistent
with previous findings of two prior studies that investigated the association between
vitamin D and bone density among premenopausal women.21, 22 The case-control study21
found a null association, while the cross-sectional study22 that examined the association
between serum 25-hydroxyvitamin D and bone mineral density among premenopausal
women found that vitamin D was positively associated with bone mineral density. Even
though one of these studies adjusted for age and body mass index,22 neither of these
studies controlled for important confounding factors such as calcium intake and physical
activity.21, 22 Further, we examined the relationship between vitamin D and BMC and BA
also adjusting for ever smoke, caloric intake and protein intake. This could be the
reasoning why our results are not consistent with the aforementioned studies. The
relationship between Vitamin D and BMC and BA may have been different in the other
two studies if they had collected data on these important confounding factors, calcium
intake, physical activity, ever smoke, caloric intake and protein intake.
The two studies were similar in both exposure and outcome assessment. In the
cross-sectional study, Adami et al. collected serum samples of healthy premenopausal
women with regular monthly cyclic menses.22 Evaluation of bone mineral density was
performed via dual-energy X-ray absorptiometry (DXA) scan at the lumbar spine and the
femoral neck. In the case-control study, Olama et al. collected venous blood samples of
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25-hydroxivitamin D in patients with fibromyalgia syndrome.21 Bone mineral density
was measured at the lumbar spine, femoral neck, and forearm by DXA. Thus, both
studies were similar in exposure and slightly similar in outcome assessment. These
previous studies looked at bone mineral density in specific regions, while ours looked at
total body BMC and BA, which could further explain the different findings.
For the unadjusted results in the study conducted by Adami et al, the relationship
between the logarithmic values of 25-hydroxyvitamin D concentrations and spine BMD,
femoral neck BMD and total hip BMD is +0.025 (non-significant p-value >0.1), -0.074
(P=0.034), and -0.047 (non-significant p-value >0.1), respectively. In the study
conducted by Olama et al., after adjustment, serum levels of 25-hydroxyvitamin D were
inversely correlated with BMD at lumbar spine (p = 0.012), and null for femoral neck and
forearm locations.
In the only cross-sectional study to assess 25-hydroxyvitamin D levels and bone
mineral density in healthy premenopausal women, Adami et al., after adjustment for age
and BMI, the regression coefficients between 25-hydroxyvitamin D concentrations and
spine and femoral neck bone mineral density were +0.084 grams per centimeter squared
(p=0.043) and +0.013 grams per centimeter squared (non-significant p-value),
respectively.22 Similar to the previous literature, this study did not measure self-reported
dietary vitamin D values from a food frequency questionnaire.
Our study is not similar to these findings, in that Adami et al. found a positive
association between serum 25-hydroxyvitamin D and both BMC and BA, while our
results were null. The outcomes were different across studies in comparison to our study
methods. Olama et al found a null association with a sample size of 100, whose null
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results may be due to the sample size. While Adami et al found a positive association
with a sample size of 608. Both of these studies had bone mineral density, measured in
grams per centimeter squared as an outcome. Contrastingly, the present study used bone
mineral content, measured in grams, and bone area, measured in centimeters squared. As
we did not evaluate bone mineral density, but rather bone mineral content and bone area,
this could explain the different findings of our null results from the current literature.
In the cross-sectional study conducted by Adami et al., the level of 25hydroxyvitamin D where an association between serum 25-hydroxyvitamin D and bone
mineral density was detectable was 20 ng/ml. In comparing this to the present study, this
value is equivalent to 50 nmol/L. Our mean for 25-hydroxyvitamin D concentrations was
88.0 nmol/L, with a standard deviation of 36.7 nmol/L. Given these values, our study
does not have enough power to detect an association between serum 25-hydroxyvitamin
D concentrations at the low end of the range and bone density.

Non-differential misclassification of vitamin D
The Harvard Food Frequency Questionnaire was previously validated by Willett
et al., indicating that a single FFQ is valid and reproducible for assessing micronutrient
intake.26 Vitamin D intake was calculated using a modified version of the Harvard Food
Frequency questionnaire. However, it is possible that women incorrectly reported their
intake of vitamin D-rich foods, due to a misunderstanding of what constitutes a single
serving of food. To the extent that non-differential misclassification occurs, our observed
association for the continuous assessment of vitamin D intake would be an underestimate
of the true association, causing a bias toward the null. In the present study, the
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relationship between total vitamin D and vitamin D from foods and bone mineral density
and bone area suggest a null relationship. Therefore, non-differential misclassification of
vitamin D on the food frequency questionnaire is possible. Further, non-differential
misclassification of nutrients is common in nutritional epidemiological studies.
Vitamin D status was measured using fasting blood samples of serum 25hydroxyvitamin D3 concentrations. Any potential misclassification of exposure is due to
lab measurement error and the resulting non-differential misclassification of serum 25hydroxyvitamin D3 concentrations would underestimate the true association and result in
a bias toward the null. However, this is unlikely because the radioimmunoassay used to
measure serum 25-hydroxyvitamin D3 concentrations has been previously validated by
UMass Vitamin D Status Study research team, and both within- and between-assay
coefficient of variations were low (0.2-5.8%).28

Non-differential misclassification of bone mineral density
Bone mineral content and bone area were measured with the DXA scan. If the
measurements of bone mineral content and bone area were incorrectly measured, then the
observed association would be an underestimate of the true association. Bone mineral
content and bone area was measured with what is widely accepted as the standard.
Furthermore, the in vivo precision indicates that this method is valid and reproducible for
assessing this outcome.28 Therefore, we expect misclassification of outcome to be
unlikely and the impact to be minor.
The range of the bone measures in the present study is as follows: for bone
mineral content is 1833-3682 grams, and for bone area is 1684-2709 centimeters squared.
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In the only study that had a positive association between serum 25-hydroxyvitamin D
values and bone mineral density,22 the range of bone mineral density at the spine, femoral
neck, and total hip is: 1.051 ± 0.122 grams per centimeter squared, 0.919 ± 0.119 grams
per centimeter squared, and 0.804±0.124 grams per centimeter squared, respectively. Our
study outcomes are comparable to the study conducted by Adami et al. As determined by
the range of bone mineral content and bone area, there was a wide enough range to allow
us to see a relationship between serum 25-hydroxyvitamin D and bone mineral content
and area.

Selection Bias
The present study is cross-sectional, and as such information is collected on
exposure and outcome at the same time at baseline. Differential selection of participants
into the study based on their exposure and outcome could occur if people who were both
vitamin D deficient and had low bone mineral density were more motivated to participate.
This would cause an increase in the “a” cell, and an over-estimate of the true association.
However, selection bias is unlikely because women who participated were unaware of
their bone mineral density and vitamin D status.

Information Bias
Information bias occurs when information on disease outcome is collected in a
differential way between exposed and non-exposed groups. In this cross-sectional study,
information bias could occur if those with low bone mineral density were more motivated
to recall vitamin D intake than those with normal bone mineral density. As a result of this
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recall bias, we would see an overestimate of the frequency of exposure among those with
low bone mineral density, and a bias away from the null. Reducing this concern are
several facts. First, the Harvard Food Frequency Questionnaire used for this study to
collect vitamin D intake was previously validated by Willett et al. with high validity.26
Second, the women enrolled into the study did not know their bone mineral density at the
time of their clinic visit. Third, the food frequency questionnaire collected a wide variety
of information such as calcium, alcohol and other nutrients; thus, the participants were
unaware of hypothesis at the time of their visit. Therefore, we believe that recall bias in
this study is unlikely and the impact would be minor.

Confounding
Confounders are other risk factors for the outcome of interest (i.e. low bone
mineral density) and are also associated with the exposure of interest. However, it is
likely that residual confounding will remain after creation of the final model because not
all covariates are perfectly measured. In addition, we do not have participant information
on diseases such as the autoimmune disease, systemic lupus erythematosus. Women who
have systemic lupus erythematosus may spend less time in the sun, and thus receive less
vitamin D. As such, if systemic lupus erythematosus was negatively associated with both
vitamin D status35 and bone mineral density,36 we would observe an overestimate of the
true association. However, lupus is an uncommon disease, and therefore we would not
expect this to be a confounder.
In our study, we analyzed characteristics other than vitamin D intake of the
exposed group that could have led to their developing low bone mineral density. We
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collected information on potential confounders, including physical activity (measured as
total MET-hrs/week), sun exposure, calcium intake, total caloric intake, selective
serotonin reuptake inhibitor use, and oral contraceptive use. To reduce confounding of
the association between vitamin D and bone mineral density by these variables, we used
multivariable linear regression.

Temporal Bias
Cross-sectional studies are subject to temporal bias, an inability to determine
whether the exposure preceded the outcome. If bone mineral density influences exposure
status (i.e. vitamin D), then we cannot conclude that the intake of vitamin D intake
preceded the status of bone mineral density. We would therefore conclude that the
observed association incorrectly describes the association between vitamin D intake and
bone mineral density. However, it is unlikely that bone mineral density influences the
status of vitamin D because the proposed physiological mechanism of this association is
that vitamin D3 assists in bone mineralization. Therefore, since vitamin D3 is responsible
for the absorption of calcium into bone from the small intestine, the threat of temporal
bias is minimized.

Generalizability
One of the proposed physiological pathways for the association between vitamin
D intake and bone mineral density is that Vitamin D3 assists in bone mineralization, as it
is involved in the activation of osteoblasts and osteoclasts. Vitamin D3 is responsible for
the absorption of calcium into bone from the small intestine. There is no evidence to
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suggest this association would be different among other women not included in the study,
therefore the results should be generalizable to most people. If the physiological
mechanism for the association between vitamin D intake and bone mineral density is
different among men, then the observed association could not be generalized to men.
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CHAPTER 5
CONCLUSION
In our study, vitamin D was not associated bone mineral density outcomes. Our
results indicated a null association between vitamin D and BMC and BA, a null
association between vitamin D from foods and BMC and BA, and a null association
between serum 25-hydroxyvitamin D and BMC and BA. The previous study conducted,
which found a positive relationship between serum 25-hydroxyvitamin D and bone
mineral density, was substantially larger.17 Further studies with larger sample sizes as
well as with daily FFQ recordings, are warranted to make a public health
recommendation of peak bone mass with vitamin D intake.
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